MARINUS PHARMACEUTICALS, INC. Increase (Decrease) in Contract with Customer, Asset
MARINUS PHARMACEUTICALS, INC. reported Increase (Decrease) in Contract with Customer, Asset of -$1.58 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2024-11-12
- MARINUS PHARMACEUTICALS, INC. increase (decrease) in contract with customer, asset for the quarter ending 2024-09-30 was -$541.00K.
- MARINUS PHARMACEUTICALS, INC. increase (decrease) in contract with customer, asset for the quarter ending 2024-06-30 was -$518.00K.
- MARINUS PHARMACEUTICALS, INC. increase (decrease) in contract with customer, asset for the quarter ending 2024-03-31 was -$522.00K.
- MARINUS PHARMACEUTICALS, INC. increase (decrease) in contract with customer, asset for the quarter ending 2023-12-31 was -$534.00K.
- MARINUS PHARMACEUTICALS, INC. increase (decrease) in contract with customer, asset for fiscal 2023 was -$2.61M.
- MARINUS PHARMACEUTICALS, INC. increase (decrease) in contract with customer, asset for fiscal 2022 was -$17.89M, a 4058.85% decline from fiscal 2021.
- MARINUS PHARMACEUTICALS, INC. increase (decrease) in contract with customer, asset for fiscal 2021 was $452.00K.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 9 month | Increase (Decrease) in Contract with Customer, Asset 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$541.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.06M derived: sum of 2 quarters · filed 2024-11-12 | -$1.58M 10-Q · filed 2024-11-12 | -$2.12M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | -$518.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$1.04M 10-Q · filed 2024-08-13 | -$1.57M derived: sum of 3 quarters · filed 2024-08-13 | -$2.08M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-03-31 | -$522.00K 10-Q · filed 2024-05-08 | -$1.06M derived: sum of 2 quarters · filed 2024-05-08 | -$1.57M derived: sum of 3 quarters · filed 2024-11-12 | -$2.59M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-12-31 | -$534.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$1.04M derived: sum of 2 quarters · filed 2024-11-12 | -$2.07M derived: sum of 3 quarters · filed 2024-11-12 | -$2.61M 10-K · filed 2024-03-05 |
| 2023-09-30 | -$510.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.53M derived: sum of 2 quarters · filed 2024-11-12 | -$2.08M 10-Q · filed 2024-11-12 | -$8.92M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$1.57M 10-Q · filed 2024-08-13 | -$8.41M derived: sum of 3 quarters · filed 2024-08-13 | -$8.90M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$544.00K 10-Q · filed 2024-05-08 | -$7.38M derived: sum of 2 quarters · filed 2024-05-08 | -$7.87M derived: sum of 3 quarters · filed 2024-05-08 | -$8.39M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$6.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$7.33M derived: sum of 2 quarters · filed 2024-03-05 | -$7.85M derived: sum of 3 quarters · filed 2024-03-05 | -$17.89M 10-K · filed 2024-03-05 |
| 2022-09-30 | -$491.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$1.01M derived: sum of 2 quarters · filed 2023-11-07 | -$11.06M 10-Q · filed 2023-11-07 | -$11.62M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$521.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$10.57M 10-Q · filed 2023-08-10 | -$11.13M derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$10.04M 10-Q · filed 2023-05-11 | -$10.61M derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$566.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $452.00K 10-K · filed 2023-03-09 | ||
| 2021-09-30 | $1.02M 10-Q · filed 2022-11-07 |